Mercator Medical S.A. (FRA:MM2)

Mercator Medical Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	131.68	123.15	217.33	223.34	339.61	399.84
Short-Term Investments	-	126.96	109.53	198.46	195.7	147.32
Cash & Short-Term Investments	131.68	250.11	326.86	421.8	535.3	547.16
Cash Growth	-47.35%	-23.48%	-22.51%	-21.20%	-2.17%	3601.26%
Accounts Receivable	95.06	91.86	61.17	49.97	99.27	97.13
Other Receivables	3.48	23.76	42.51	19.54	25.32	19.28
Receivables	158.81	168.72	104.11	69.92	124.6	116.42
Inventory	192.34	214.65	153.09	204.67	253.36	429.6
Prepaid Expenses	-	0.49	0.52	0.45	0.56	0.43
Other Current Assets	71.81	0.7	0.66	0.72	0.35	1.92
Total Current Assets	554.63	634.67	585.24	697.56	914.17	1,096
Property, Plant & Equipment	332.43	310.79	251.66	281.96	334.65	183.41
Long-Term Investments	-	5.63	2.01	0.73	-	-
Other Intangible Assets	28.83	31.75	33.14	24.11	9.65	3.87
Long-Term Deferred Tax Assets	31.42	29.85	24.16	29.7	28.38	6.49
Other Long-Term Assets	56.52	10.78	2.96	4.05	1.68	0.02
Total Assets	1,004	1,043	965.23	1,083	1,289	1,289
Accounts Payable	70.5	77.29	53.49	35.8	62.41	100.58
Accrued Expenses	-	10.1	9.61	12.85	16.03	22.81
Short-Term Debt	0.08	0.05	0.15	0.21	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	0.69
Current Portion of Leases	3.8	1.44	0.85	0.72	1.31	1.54
Current Income Taxes Payable	0.2	2.4	4.24	0.03	24.61	89.42
Current Unearned Revenue	-	0.2	0.63	3.1	27.72	23.56
Other Current Liabilities	5.19	5.4	9.51	7.25	0.97	1.31
Total Current Liabilities	79.77	96.87	78.47	59.96	133.05	239.89
Long-Term Leases	19.69	3.07	4.41	2.46	3.52	2.02
Long-Term Unearned Revenue	-	-	0.15	0.16	0.16	0.17
Long-Term Deferred Tax Liabilities	11.67	15.78	20.87	8.54	4.35	2.96
Other Long-Term Liabilities	2.66	2.55	1.61	2.73	2.23	1.13
Total Liabilities	113.78	118.28	105.52	73.85	143.32	246.17
Common Stock	9.27	9.77	10.65	10.65	10.65	10.6
Additional Paid-In Capital	30.74	30.74	30.74	57.84	57.84	57.14
Retained Earnings	900.54	895.17	854.82	888.22	1,079	963.76
Comprehensive Income & Other	-47.43	-7.36	-34.12	52.02	-3.28	8.45
Total Common Equity	893.11	928.32	862.09	1,009	1,144	1,040
Minority Interest	-3.06	-3.16	-2.38	0.49	1.36	3.18
Shareholders' Equity	890.05	925.16	859.71	1,009	1,145	1,043
Total Liabilities & Equity	1,004	1,043	965.23	1,083	1,289	1,289
Total Debt	23.58	4.56	5.41	3.39	4.83	4.25
Net Cash (Debt)	108.1	245.55	321.45	418.41	530.47	542.91
Net Cash Growth	-55.97%	-23.61%	-23.17%	-21.12%	-2.29%	-
Net Cash Per Share	11.57	26.15	33.54	42.82	52.41	51.56
Filing Date Shares Outstanding	9.65	9.77	9.77	10.65	10.65	10.41
Total Common Shares Outstanding	9.65	9.77	9.42	10.65	10.65	10.41
Working Capital	474.87	537.8	506.76	637.6	781.12	855.63
Book Value Per Share	92.58	95.01	91.54	94.74	107.43	99.92
Tangible Book Value	864.28	896.57	828.95	984.62	1,134	1,036
Tangible Book Value Per Share	89.59	91.76	88.02	92.48	106.53	99.55
Land	-	45.99	41.8	47.24	51.94	8.78
Buildings	-	118.6	100.87	110.96	79.99	74.45
Machinery	-	274.18	223.41	201.74	172.21	170.27
Construction In Progress	-	5.68	1.07	32.75	115.12	4.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.